153 related articles for article (PubMed ID: 37776258)
1. Cancer Biomarkers V: Update on B-Cell Lymphoma Biomarkers.
Crane GM
Arch Pathol Lab Med; 2024 May; 148(5):e90-e95. PubMed ID: 37776258
[TBL] [Abstract][Full Text] [Related]
2. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
Solé C; Larrea E; Di Pinto G; Tellaetxe M; Lawrie CH
Cancer Lett; 2017 Oct; 405():79-89. PubMed ID: 28757417
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas.
Behdad A; Bailey NG
Surg Pathol Clin; 2016 Mar; 9(1):41-54. PubMed ID: 26940267
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. The Polymerase Chain Reaction in Diagnosis of Small B-Cell Non-Hodgkin Lymphomas.
Antoro EL; Dwianingsih EK; Indrawati ; Triningsih FE; Harijadi
Asian Pac J Cancer Prev; 2016; 17(2):491-5. PubMed ID: 26925633
[TBL] [Abstract][Full Text] [Related]
6. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
O'Malley DP; Auerbach A; Weiss LM
Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
[TBL] [Abstract][Full Text] [Related]
7. Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma.
Iqbal J; Joshi S; Patel KN; Javed SI; Kucuk C; Aabida A; d'Amore F; Fu K
Indian J Cancer; 2007; 44(2):72-86. PubMed ID: 17938484
[TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
9. Pathology consultation on intermediate-to-large B-cell lymphomas.
Montgomery ND; Fedoriw Y
Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD-L1 and predicts poor prognosis in B-cell lymphoma.
Liu X; Zhang Y; Han Y; Lu W; Yang J; Tian J; Sun P; Yu T; Hu Y; Zhang H; Huang P; Liu P
Mol Oncol; 2020 May; 14(5):1028-1044. PubMed ID: 32157792
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
[TBL] [Abstract][Full Text] [Related]
12. Predictive and prognostic molecular biomarkers in lymphomas.
Iorgulescu JB; Medeiros LJ; Patel KP
Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.
Onaindia A; Medeiros LJ; Patel KP
Mod Pathol; 2017 Oct; 30(10):1338-1366. PubMed ID: 28664939
[TBL] [Abstract][Full Text] [Related]
14. The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms.
Seegmiller AC; Hsi ED; Craig FE
Cytometry B Clin Cytom; 2019 Jan; 96(1):20-29. PubMed ID: 30549186
[TBL] [Abstract][Full Text] [Related]
15. Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.
Grange B; Callet-Bauchu E; Salles G; Sujobert P
Expert Rev Mol Diagn; 2017 Jun; 17(6):623-632. PubMed ID: 28480776
[TBL] [Abstract][Full Text] [Related]
16. Pathology of B-cell lymphomas: diagnosis and biomarker discovery.
Ondrejka SL; Hsi ED
Cancer Treat Res; 2015; 165():27-50. PubMed ID: 25655605
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.
Iqbal J; Shen Y; Huang X; Liu Y; Wake L; Liu C; Deffenbacher K; Lachel CM; Wang C; Rohr J; Guo S; Smith LM; Wright G; Bhagavathi S; Dybkaer K; Fu K; Greiner TC; Vose JM; Jaffe E; Rimsza L; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Armitage JO; Weisenburger DD; Staudt LM; Gascoyne RD; McKeithan TW; Chan WC
Blood; 2015 Feb; 125(7):1137-45. PubMed ID: 25498913
[TBL] [Abstract][Full Text] [Related]
19. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
Rodig SJ; Kutok JL; Paterson JC; Nitta H; Zhang W; Chapuy B; Tumwine LK; Montes-Moreno S; Agostinelli C; Johnson NA; Ben-Neriah S; Farinha P; Shipp MA; Piris MA; Grogan TM; Pileri SA; Gascoyne RD; Marafioti T
Haematologica; 2010 Dec; 95(12):2056-62. PubMed ID: 20823132
[TBL] [Abstract][Full Text] [Related]
20. ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
Ladetto M; Buske C; Hutchings M; Dreyling M; Gaidano G; Le Gouill S; Luminari S; Pott C; Zamò A; Zucca E;
Ann Oncol; 2016 Dec; 27(12):2149-2160. PubMed ID: 27701070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]